Labiotech.eu’s Coverage of the Covid-19 Coronavirus
Like many others, the biopharma industry has been shaken by the rapid rise of the…
19/03/2020 - 13 minutes
More News!
Every week, we gather all the science news that we didn’t cover in depth for those that want to keep up with everything going on in the industry.
ADVERTISEMENT
Do you want to remove this advert? Become a member!
Update: First Ever Ebola Vaccine Gets US and EU Approval
Update (20/12/2019): After getting conditional approval in Europe in November, Merck has received FDA approval…
20/12/2019 - 2 minutes
Transgene’s Cancer Vaccine Abandoned after Phase II Fail
French biotech Transgene has ceased the development of a therapeutic cancer vaccine that failed to…
13/12/2019 - 2 minutes
Scientists Use DNA Data Storage to Hide Information in Everyday Objects
Scientists have developed a method for storing DNA data in 3D-printed objects, which could one…
09/12/2019 - 4 minutes
Update: Cancer Immunotherapy Biotech Files for Insolvency
Update (06/12/2019): Following the phase III failure of its immunotherapy drug for colorectal cancer in…
06/12/2019 - 2 minutes
Scientists Turn Crop Waste into Fragrances with Microbes
A team of researchers in Brazil and the UK has developed a fermentation technique to…
27/11/2019 - 2 minutes
Novartis Enters RNA Therapeutics with Medicines Company Merger
Novartis is to acquire The Medicines Company and its late-stage RNA interference drug designed to…
25/11/2019 - 3 minutes
€37.4M Invested in Azeria Therapeutics’ Cancer Treatment Program
UK-based Azeria Therapeutics has raised a Series B investment round of €37.4M to fund development…
21/11/2019 - 3 minutes
US-French Deal to Tailor Ultrasound Therapy to Brain Cancer Patients
The French company CarThera has teamed up with the US firm Kiyatec to study the…
19/11/2019 - 2 minutes
First Results Out for Off-the-Shelf CAR-T Therapy in Solid Tumors
The Belgian company Celyad has released the first interim clinical efficacy data for an off-the-shelf…
12/11/2019 - 2 minutes
Argenx Raises Whopping €502M in Global Offering
The Dutch biotech argenx, which develops antibody drugs to treat autoimmune diseases and cancer, has…
11/11/2019 - 2 minutes
UK Biotech Launched to Target ‘Dark Antigens’ with Cancer Vaccines
The London-based startup Ervaxx has launched with a €15.8M Series A round to develop cancer…
06/11/2019 - 2 minutes
